
Overview
Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division.
Dr. Mccormack is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.
Her clinical research consists of co-authoring 219 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Sarcoidosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5501 Hopkins Bayview Circle, Allergy & Asthma Center, 2nd Floor, Allergy & Asthma Center, 2nd Floor, Baltimore, MD 21224
Additional Areas of Focus
Dr. Mccormack has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Johns Hopkins University
David Moller is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Moller is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Interstitial Lung Disease, and Acute Interstitial Pneumonia.
Johns Hopkins Bayview Medical Center
Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.
Inova Health Care Services
Steven Nathan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Falls Church, Virginia. Dr. Nathan is rated as an Elite provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy. Dr. Nathan is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AsthmaDr. Mccormack isElite. Learn about Asthma.
- Chronic Obstructive Pulmonary Disease (COPD)
- Distinguished
- Acute Interstitial PneumoniaDr. Mccormack isDistinguished. Learn about Acute Interstitial Pneumonia.
- Interstitial Lung DiseaseDr. Mccormack isDistinguished. Learn about Interstitial Lung Disease.
- SarcoidosisDr. Mccormack isDistinguished. Learn about Sarcoidosis.
- Advanced
- Asthma in ChildrenDr. Mccormack isAdvanced. Learn about Asthma in Children.
- Cerebral HypoxiaDr. Mccormack isAdvanced. Learn about Cerebral Hypoxia.
- Cystic FibrosisDr. Mccormack isAdvanced. Learn about Cystic Fibrosis.
- EmphysemaDr. Mccormack isAdvanced. Learn about Emphysema.
- Hypersensitivity PneumonitisDr. Mccormack isAdvanced. Learn about Hypersensitivity Pneumonitis.
- Idiopathic Pulmonary FibrosisDr. Mccormack isAdvanced. Learn about Idiopathic Pulmonary Fibrosis.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Mccormack isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Allergic Bronchopulmonary AspergillosisDr. Mccormack isExperienced. Learn about Allergic Bronchopulmonary Aspergillosis.
- AspergillosisDr. Mccormack isExperienced. Learn about Aspergillosis.
- BronchiectasisDr. Mccormack isExperienced. Learn about Bronchiectasis.
- Bronchiolitis ObliteransDr. Mccormack isExperienced. Learn about Bronchiolitis Obliterans.
- BronchitisDr. Mccormack isExperienced. Learn about Bronchitis.
